Merck sues HHS over drug negotiation, claims program ‘tantamount to extortion’
The New Jersey-based company is asking the U.S. District Court for the District of Columbia for an injunction to stop the rules from going into effect over the next several months. “Because this statute unlawfully impairs our core purpose of engaging in innovative research that saves and improves…
#newjersey #usdistrictcourt #merck #ussupremecourt #robertjosephson #hhs #cms #medicare #fifthamendments #firstamendments